SEC Form 4 · accession 0000883943-16-000138
CHRISTOPHER & BANKS CORP · CBK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter G Michielutti
Officer — EVP, COO & CFO
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883943
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Sep 1, 2016 | A | 17,688 | $0.00 | A | 91,554 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F6 | $2.12 | Sep 1, 2016 | A | 129,028 | A | Sep 1, 2017 | Sep 1, 2026 | Common Stock | 129,028 | 129,028 | D |
| Employee Stock Option (Right to Buy)F4 | $1.86 | holding | — | — | — | Apr 19, 2013 | Apr 23, 2022 | Common Stock | 30,000 | 30,000 | D |
| Employee Stock Option (Right to Buy)F5 | $6.25 | holding | — | — | — | Mar 15, 2014 | Mar 15, 2023 | Common Stock | 13,755 | 13,755 | D |
Explanation of responses
- F1For purposes of setting the exercise price of the non-qualified stock option ("NQSO") award and for calculating both the time-based restricted stock and NQSO awards granted on September 1, 2016, the Company used a price of $2.12 per share which represents the highest closing price on the NYSE during the 30 trading days preceding the date of grant.
- F2The reporting person was granted 17,688 shares of Common Stock pursuant to a Restricted Stock Agreement. The shares are subject to forfeiture and are scheduled to vest in three annual installments of 5,896 shares on each of September 1, 2017, September 1, 2018 and September 1, 2019.
- F3This number includes restricted stock awards.
- F4On April 23, 2012, the reporting person was granted an option to purchase 30,000 shares of the Company's Common Stock that becomes fully exercisable on April 19, 2013. The option is subject to accelerated vesting in the event the reporting person is terminated by the Company, other than for cause, and accelerated vesting on a pro rata basis in the event of his death or disability.
- F5On March 15, 2013, the reporting person was granted an option to purchase 13,755 shares of the Company's Common Stock. The option vests in three annual installments of 4,585 shares on each of March 15, 2014, March 15, 2015 and March 15, 2016.
- F6On September 1, 2016, the reporting person was granted an option to purchase 129,028 shares of the Company's Common Stock. The option vests in three annual installments of 43,010 shares on September 1, 2017, 43,009 shares on September 1, 2018 and 43,009 shares on September 1, 2019.